All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @c.agost on TikTok · 59s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @c.agost's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Hi, my name is Kao. I'm one week on T. I'm doing testosterone 1.62% gel
  2. 0:07I do two pumps a day one on each my shoulders on the outside and I rub it in
  3. 0:13I've been really enjoying this because I do not mess with needles. I would have hated that
  4. 0:19And my doctor just recommended it based on like my tests and stuff
  5. 0:24One thing that's been like super annoying though
  6. 0:25Is I feel like I get so much left on my hands and I wash my hand and it comes off and it's not getting into my skin
  7. 0:31I'm assuming it's a negligible amount
  8. 0:34um
  9. 0:35And it's super annoying sorry not being able to like put clothes on right after and
  10. 0:40I have a girlfriend and two cats and I don't wish to get any of them on
  11. 0:46Tea, you know so
  12. 0:49That's funny
  13. 0:50but otherwise super enjoying it and
  14. 0:52The most annoying boy are actually is making those videos every week of my voice I keep forgetting

First week on testosterone: what TikTok gets right and wrong

Cal

TikTok creator

14.2K viewsWatch on TikTok

Quick answer

The creator is one week into gender-affirming testosterone therapy using 1.62% testosterone gel applied bilaterally to the outer deltoid, a standard initiation protocol supported by Endocrine Society guidelines. The primary clinical question raised is secondary transdermal transfer risk via hand residue, which the FDA has flagged with a black box warning for all topical testosterone products. Labs were confirmed prior to prescribing, which reflects appropriate baseline monitoring before therapy initiation.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For First week on testosterone: what TikTok gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

First week on testosterone: what TikTok gets right and wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "First week on testosterone: what TikTok gets right and wrong" from Cal. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is one week into gender-affirming testosterone therapy using 1.

The reason this review is not generic is the source wording and the canonical claim label "trt one week down i m so excited and happy transman ftmtransgend." In this clip, the useful excerpt is: "Hi, my name is Kao." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Washing hands immediately after application reduces but does not eliminate residue transfer risk.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is one week into gender-affirming testosterone therapy using 1.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is one week into gender-affirming testosterone therapy using 1.62% testosterone gel applied bilaterally to the outer deltoid, a standard initiation protocol supported by Endocrine Society guidelines. The primary clinical question raised is secondary transdermal transfer risk via hand residue, which the FDA has flagged with a black box warning for all topical testosterone products. Labs were confirmed prior to prescribing, which reflects appropriate baseline monitoring before therapy initiation.
  • The FDA issued a black box warning for all topical testosterone gels specifically due to secondary exposure risk, documented in children and partners through incidental skin-to-skin contact.
  • Washing hands immediately after application reduces but does not eliminate residue transfer risk. The FDA's guidance is to prevent contact, not to assume remaining amounts are harmless.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The FDA issued a black box warning for all topical testosterone gels specifically due to secondary exposure risk, documented in children and partners through incidental skin-to-skin contact.
  • Washing hands immediately after application reduces but does not eliminate residue transfer risk. The FDA's guidance is to prevent contact, not to assume remaining amounts are harmless.
  • 1.62% testosterone gel applied to the outer deltoid bilaterally is a guideline-consistent application method for gender-affirming testosterone therapy (Hembree et al., 2017, J Clin Endocrinol Metab).
  • Voice changes from testosterone therapy typically begin between 3-6 months of continuous use, making week-one voice tracking premature for detecting clinical change.
  • Female companion animals, including cats, can experience reproductive and hormonal effects from repeated low-level testosterone exposure, making transfer precautions relevant beyond human household members.
  • Gel formulations produce more stable daily serum testosterone levels than weekly injections but require strict daily adherence and site rotation to maintain consistent absorption.
  • Serum testosterone monitoring after initiating gel therapy is typically recommended at 6-8 weeks to assess levels and adjust dosing if needed before the 3-month follow-up.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @c.agost actually say?

One week into testosterone gel therapy, Kao described using 1.62% testosterone gel, two pumps daily applied to the outside of each shoulder. The main complaint was residue left on hands after application, which they assumed was "a negligible amount" that washes off. They also flagged the need to avoid skin contact with a girlfriend and two cats until the gel dries.

To be clear: this is gender-affirming hormone therapy, not performance enhancement. That context matters for how we interpret the clinical picture. The creator isn't making extraordinary claims. They're sharing a routine experience and, importantly, raising a real safety question about secondary transfer, even if they framed it casually.

Does the science back this up?

On the transfer question, the concern is legitimate and the FDA takes it seriously. The "negligible amount" assumption deserves more scrutiny than Kao gave it.

The FDA issued a black box warning for testosterone gel products specifically because of secondary exposure risks. Studies have documented virilization in children and partners through incidental skin contact. A 2009 case series published in Pediatrics (Bhatt et al.) documented premature pubic hair and clitoral enlargement in young children whose fathers used testosterone gel and didn't follow transfer precautions rigorously.

The hand residue issue is real, not trivial. Research on AndroGel pharmacokinetics shows that testosterone absorbed through palmar skin is less efficient than deltoid or shoulder application, but the hands do absorb some amount before washing. The FDA recommends washing hands immediately after application, which Kao does, and that does significantly reduce residue. So the "wash it off" behavior is correct, even if calling leftovers "negligible" is an oversimplification.

For cats specifically, veterinary toxicology literature confirms that exogenous androgen exposure in female cats can cause behavioral changes and reproductive abnormalities. This isn't a hypothetical.

What did they get wrong (or right)?

Mostly right, with one soft error. Applying gel to the outer shoulder is consistent with prescribing guidelines for 1.62% formulations like Vogelxo or generic equivalents. Two pumps daily is a standard starting point, and Kao's doctor ordered labs before prescribing, which is exactly how this should work.

The one thing worth pushing back on: describing hand residue as "a negligible amount" is too casual. It's probably a small amount, yes, but the correct framing is: wash hands immediately (Kao does this), avoid contact with others until the site is dry (Kao also does this), and cover the application site before contact. The FDA's guidance doesn't use the word "negligible." It says prevent contact. That's a meaningful difference when you have a girlfriend who could experience hormonal side effects from repeated low-level exposure over weeks or months.

Credit where it's due: most people starting testosterone gel don't think about their pets at all. The cats comment was funny, but it reflects genuine awareness of a real exposure pathway that even some prescribers don't discuss explicitly.

What should you actually know?

If you're starting testosterone gel, the transfer protocol isn't optional fine print. It's the part that protects the people around you. Cover the application site with clothing after it dries (typically 2-5 minutes). Wash hands with soap and water immediately after applying. If a partner or child accidentally contacts the application site, they should wash the exposed skin with soap and water right away.

For people assigned female at birth using testosterone for gender-affirming care, serum testosterone monitoring typically begins 6-8 weeks after starting therapy (Hembree et al., 2017, Journal of Clinical Endocrinology and Metabolism). Gel formulations produce steadier daily levels than injections but require strict adherence to application timing and site rotation.

One week in is genuinely too early to evaluate most clinical outcomes. Voice changes, which Kao is tracking, typically begin appearing between 3-6 months of therapy. Tracking weekly audio is a smart long-game move, even if week one sounds identical to week zero.

Bottom line on this video

This is a pretty responsible first-week check-in. The transfer precautions Kao is taking are correct. The "negligible" framing of hand residue is the one place where more caution would be warranted, not less. Secondary testosterone exposure is documented in humans and animals, and the right word is "minimize," not "negligible." Otherwise, Kao's approach reflects what a well-managed gel protocol actually looks like in practice.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Cal · TikTok creator

14.2K views on this video

One week down, I’m so excited and happy :) #transman #ftmtransgender #lgbt🏳️‍🌈 #lgbtq #ftm

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the fda?

The FDA issued a black box warning for all topical testosterone gels specifically due to secondary exposure risk, documented in children and partners through incidental skin-to-skin contact.

What does the video say about washing hands immediately after application reduces?

Washing hands immediately after application reduces but does not eliminate residue transfer risk. The FDA's guidance is to prevent contact, not to assume remaining amounts are harmless.

What does the video say about 1.62% testosterone gel applied to the outer deltoid bilaterally?

1.62% testosterone gel applied to the outer deltoid bilaterally is a guideline-consistent application method for gender-affirming testosterone therapy (Hembree et al., 2017, J Clin Endocrinol Metab).

What does the video say about voice changes from testosterone therapy typically begin between 3-6 months?

Voice changes from testosterone therapy typically begin between 3-6 months of continuous use, making week-one voice tracking premature for detecting clinical change.

What does the video say about female companion animals, including cats, can experience reproductive?

Female companion animals, including cats, can experience reproductive and hormonal effects from repeated low-level testosterone exposure, making transfer precautions relevant beyond human household members.

What does the video say about gel formulations produce more stable daily serum testosterone levels than?

Gel formulations produce more stable daily serum testosterone levels than weekly injections but require strict daily adherence and site rotation to maintain consistent absorption.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Cal, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.